πŸ‡ΊπŸ‡Έ FDA
Patent

US 8653070

Hepatitis C virus inhibitors

granted A61KA61K38/00A61P

Quick answer

US patent 8653070 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P31/12, A61P31/14